The newest interleukins: recent additions to the ever-growing cytokine family (Q36617094)

15 August 2017

1 reference

title

The newest interleukins: recent additions to the ever-growing cytokine family (English)

1 reference

15 August 2017

Qian Chen

1

1 reference

15 August 2017

Helen P Carroll

series ordinal

2

1 reference

15 August 2017

Massimo Gadina

series ordinal

3

1 reference

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

published in

Vitamins and Hormones

1 reference

15 August 2017

volume

74

1 reference

15 August 2017

page(s)

207-228

1 reference

The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

WSX-1: a key role in induction of chronic intestinal nematode infection

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Molecular phylogeny within type I cytokines and their cognate receptors

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Interleukin-4 and interleukin-13: their similarities and discrepancies

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Epstein–Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

1 reference

7 January 2021

GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor Receptor

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Characterization of the signaling capacities of the novel gp130-like cytokine receptor

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Cytokine therapeutics: lessons from interferon alpha

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Interleukin-32: a cytokine and inducer of TNFalpha

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

1 reference

7 January 2021

IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

A novel negative regulator for IL-1 receptor and Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Crystal structure of the cytokine interleukin-1 beta.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

No inhibition of IL-27 signaling by soluble gp130.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1)

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

The biology of TNF blockade

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

NC/Nga mice: a mouse model for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Gp130 and the interleukin-6 family of cytokines

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

WSX-1 over-expression in CD4( ) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Positive and negative regulation of the IL-27 receptor during lymphoid cell activation.

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0083-6729(06)74008-0

7 January 2021

10.1016/S0083-6729(06)74008-0

Identifiers

DOI

1 reference

15 August 2017

1 reference